|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-8-18
|
|
pubmed:abstractText |
Circulating erythropoietin (EPO) and vascular endothelial growth factor (VEGF) increase during hypoglycaemia and may represent protective hormonal counter-regulatory responses. We tested the hypothesis that low levels of EPO and VEGF are associated with a higher frequency of severe hypoglycaemia in a cohort of patients with type 1 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1479-683X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
163
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
391-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20566589-Adult,
pubmed-meshheading:20566589-Age Factors,
pubmed-meshheading:20566589-Biological Markers,
pubmed-meshheading:20566589-Diabetes Mellitus, Type 1,
pubmed-meshheading:20566589-Erythropoietin,
pubmed-meshheading:20566589-Female,
pubmed-meshheading:20566589-Follow-Up Studies,
pubmed-meshheading:20566589-Humans,
pubmed-meshheading:20566589-Hypoglycemia,
pubmed-meshheading:20566589-Male,
pubmed-meshheading:20566589-Middle Aged,
pubmed-meshheading:20566589-Prospective Studies,
pubmed-meshheading:20566589-Risk Factors,
pubmed-meshheading:20566589-Severity of Illness Index,
pubmed-meshheading:20566589-Sex Factors,
pubmed-meshheading:20566589-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes.
|
|
pubmed:affiliation |
Endocrinology Section, Department of Cardiology and Endocrinology, Hillerød Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark. pelk@hih.regionh.dk
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
